Valneva SE AYJ
$2.69
▼ -0.13% 24H
About
Valneva SE is a specialty vaccine company headquartered in Saint-Herblain, France, that develops, manufactures, and commercializes prophylactic vaccines targeting infectious diseases with significant unmet medical needs. Its commercial portfolio features three key vaccines: IXIARO®, for Japanese encephalitis; DUKORAL®,…
SectorHealthcare
ExchangeXETR
IndustryBiotechnology
CountryFrance
Employees700
TickerAYJ
Statistics
Market Cap$467.8M
Revenue (TTM)$167.3M
Net Income—
Net Margin—
EPS—
P/E70.98
P/S2.80
P/B5.36
EV/EBITDA-6.29
ROE-109.6%
Dividend Yield—
Price$2.69
Data: Twelve Data · Revenue = mcap / P/S